Endotoxin Testing: A Separate Test From Purity, and Why It Exists

Endotoxins are a component of the outer membrane of gram-negative bacteria, released when those bacterial cells die or divide. They are not the bacteria themselves, and a batch can carry a meaningful endotoxin load even when no viable organism is present, which is exactly why sterility testing and endotoxin testing are two separate procedures answering two separate questions rather than one test standing in for the other.

A synthesis and manufacturing process can introduce endotoxins at multiple points: raw materials, water used in processing, or equipment and surfaces that were not adequately controlled. Because peptide synthesis is a multi-step process, contamination introduced early can persist through later steps if it is not specifically tested for at the end.

The standard method for detecting and quantifying endotoxin is the LAL test, short for Limulus Amebocyte Lysate, which reacts with bacterial endotoxin in a way that produces a measurable result, typically expressed in endotoxin units per milligram or per vial. Kinetic and chromogenic variants of the LAL method allow labs to quantify endotoxin levels precisely rather than simply flagging pass or fail.

Endotoxin testing sits alongside HPLC purity analysis and mass-spectrometry identity confirmation as a distinct category on a real certificate of analysis, not a substitute for either. A compound can be high purity and correctly identified by mass and still carry an endotoxin result worth knowing, which is why a complete lot-level COA reports it as its own line item rather than folding it into a general purity claim.

For a researcher, the practical takeaway is the same one that applies to every other test discussed here: ask whether endotoxin testing was actually performed on the specific lot in hand, by an independent lab, with a reported result, rather than assuming a purity figure alone covers it. It doesn't. They are different measurements of different things.